← Leaderboards
Jodi Gilman
Massachusetts General Hospital
$8,178,599
Attributed
$11,500,821
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2013–25$2.5M$1.9M$1.3M$625K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,500,821 · 5
By mechanism
R01$9,934,081 · 3
K01$925,220 · 1
K02$641,520 · 1
Top collaborators
- Marco Luciano Loggia6 shared
- A Eden Evins5 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jianren Mao$21,748,037
- A Eden Evins$20,295,171
- Xu Yu$21,799,579
- Christine S Ritchie$16,346,545
- Mathias Lichterfeld$34,368,889
Others in their field
Top investigators on “Cannabis”
- Gavin Bart · Rockefeller University$20,453,700
- Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai$18,850,706
- Deepak Cyril D'souza · Va Connecticut Healthcare System$17,740,756
- Richard A Miech · Johns Hopkins University$17,538,220
- Linda Chang · La Biomed Res Inst/ Harbor Ucla Med Ctr$17,170,784
- Herbert David Kleber · New York State Psychiatric Institute$16,737,999
Research focus
CannabisMental DepressionPainBehavioralBrainAnxietyReportingDoseRandomizedParticipantMedical MarijuanaStructureUnited StatesVisitBehaviorInterestChronicPharmaceutical PreparationsRewardsFunctional Magnetic Resonance ImagingScientistMaintenanceAddictionAdult
Grant awards (27)
Evaluation of Cannabidiol for Reduction of Brain Neuroinflammation$753,349
R01 · FY2025 · DA
Evaluation of Cannabidiol for Reduction of Brain Neuroinflammation$165,130
R01 · FY2025 · DA
Using Neuroimaging Markers to Understand Risk Factors and Consequences of Cannabis on Brain Structure and Function$128,304
K02 · FY2025 · DA · contact PI
Evaluation of Cannabidiol for Reduction of Brain Neuroinflammation$753,349
R01 · FY2024 · DA
Administrative Supplement: Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain$163,431
R01 · FY2024 · DA · contact PI
Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain$132,961
R01 · FY2024 · DA · contact PI
Using Neuroimaging Markers to Understand Risk Factors and Consequences of Cannabis on Brain Structure and Function$128,304
K02 · FY2024 · DA · contact PI
Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain$813,497
R01 · FY2023 · DA · contact PI
Evaluation of Cannabidiol for Reduction of Brain Neuroinflammation$753,349
R01 · FY2023 · DA
Using Neuroimaging Markers to Understand Risk Factors and Consequences of Cannabis on Brain Structure and Function$128,304
K02 · FY2023 · DA · contact PI
Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain$817,446
R01 · FY2022 · DA · contact PI
Evaluation of Cannabidiol for Reduction of Brain Neuroinflammation$753,349
R01 · FY2022 · DA
Using Neuroimaging Markers to Understand Risk Factors and Consequences of Cannabis on Brain Structure and Function$128,304
K02 · FY2022 · DA · contact PI
Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain$785,235
R01 · FY2021 · DA · contact PI
Evaluation of Cannabidiol for Reduction of Brain Neuroinflammation$753,349
R01 · FY2021 · DA
Medical Marijuana, Neurocognition, and Subsequent Substance Use$636,868
R01 · FY2021 · DA · contact PI
Using Neuroimaging Markers to Understand Risk Factors and Consequences of Cannabis on Brain Structure and Function$128,304
K02 · FY2021 · DA · contact PI
Medical Marijuana, Neurocognition, and Subsequent Substance Use$636,868
R01 · FY2020 · DA · contact PI
Medical Marijuana, Neurocognition, and Subsequent Substance Use$80,931
R01 · FY2020 · DA · contact PI
Medical Marijuana, Neurocognition, and Subsequent Substance Use$630,065
R01 · FY2019 · DA · contact PI
Medical Marijuana, Neurocognition, and Subsequent Substance Use$633,002
R01 · FY2018 · DA · contact PI
Medical Marijuana, Neurocognition, and Subsequent Substance Use$671,902
R01 · FY2017 · DA · contact PI
Neurobehavioral Characterization of Social Influence in Drug Addiction$185,161
K01 · FY2017 · DA · contact PI
Neurobehavioral Characterization of Social Influence in Drug Addiction$184,487
K01 · FY2016 · DA · contact PI
Neurobehavioral Characterization of Social Influence in Drug Addiction$185,992
K01 · FY2015 · DA · contact PI
Neurobehavioral Characterization of Social Influence in Drug Addiction$184,362
K01 · FY2014 · DA · contact PI
Neurobehavioral Characterization of Social Influence in Drug Addiction$185,218
K01 · FY2013 · DA · contact PI